$34.41
-2.61-7.04%
Last update: Nov 4, 7:40 PM

The average analyst price target for Harmony Biosciences Hldgs is $47.63, 38.3% above the current price. Of 13 analysts, 8 rate it Buy, 3 Hold and 2 Sell. Targets range from $28 to $70. The latest change came on Aug 26, 2026, when Wolfe Research initiated coverage of Harmony Biosciences Hldgs with an Outperform rating and a $60 price target.
Price Target Range — 12 Quarters
Analyst Consensus — 13 Analysts
Rating Trend — Last 9 Months